Different routes of steroid therapy after pediatric cataract surgery
Phase 2
- Conditions
- Health Condition 1: H260- Infantile and juvenile cataract
- Registration Number
- CTRI/2020/04/024629
- Lead Sponsor
- Dr Usha Kaul Raina
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients between 5 and 10 years of age with congenital and developmental cataract
Exclusion Criteria
Patients having active or chronic inflammation, uveitis and secondary glaucoma
Family history of glaucoma
High myopes
Presence of any gross ocular pathology like micropthalmos, aniridia,coloboma
Presence of PHPV, retinal detachment
Presence of significant corneal opacity
Significant systemic diseases which may make the child unfit for surgery
Any subluxation of the lens
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Signs of anterior segment inflammation <br/ ><br>1) Posterior synechiae <br/ ><br>2) Cells/flareTimepoint: Postoperative <br/ ><br>Day 1 <br/ ><br>Week 1 <br/ ><br>week 3 <br/ ><br>Week 6 <br/ ><br>Week 12 <br/ ><br>Over period of 3 months <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Pigments deposition on IOL <br/ ><br>Pupillary membrane <br/ ><br>Posterior Capsular Opacification <br/ ><br>Intraocular pressure <br/ ><br>Central corneal thickness <br/ ><br>Cystoid macular edemaTimepoint: Postoperative <br/ ><br>Day1 <br/ ><br>1week <br/ ><br>3week <br/ ><br>6week <br/ ><br>12week